Mike Sokoll looks at the IPO pipeline. Biotech and healthcare are both strong, but he says Nasdaq is also seeing international companies listing. He says the Fed’s rate cuts have been the biggest boost to the IPO market. However, he says there’s “no rush” to come to market right away.
Market On Close
26 Nov 2024
SHARE
Current show
Mon—Fri at 12:00 pm — 1:00 pm
Next Gen Investing